1 day ago by Paul Cacciatore

Proteomics study reveals a protein that, when suppressed, makes cancers more susceptible to chemotherapy involving taxane drugs. Taxanes, a group of cancer drugs that includes paclitaxel (Taxol®) and docetaxel (Taxotere®), have become front-line therapy for a variety of metastatic cancers. But as wi ...

Libby's H*O*P*E* - healthinfoispower.wordpress.com · 11 references

13 days ago by Paul Cacciatore

The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Ovarian Cancer to include two additional combination treatment regimens for women with select types of recurring ovarian cancer. The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Clinic ...

Libby's H*O*P*E* - healthinfoispower.wordpress.com · 11 references

15 days ago by teammccallum

A team led by Andrea L Richardson and Zhigang Charles Wang has found 2 genes that make breast cancer resistant to treatment by commonly-used drugs, called anthracyclines. This opens the way that patients with these genes can be put on more effective drugs. The team from the Dana-Farber Women’s Cance ...

Team McCallum - teammccallum.wordpress.com · 2 references

20 days ago by ligero999

Bueno, hoy amigos de la Supergalaxia os hablaré del taxol, una sustancia que se utiliza an hoy en día mucho como un potente anticanceroso. El taxol (que antiguamente se sacaba del tejo del Pacífico ( Taxus Brevifolia), que era un árbol muy frecuente en la costa oeste de Norteamérica) fue capaz de si ...

La Supergalaxia - lasupergalaxia.wordpress.com · 3 references

20 days ago by Salvo Franchina

..Ma è la loro peculiarità di azione che lascia gradevilmente incuriositi e speranzosi. Le particelle, chiamata “nanoburrs,” sono rivestite di piccoli frammenti di proteine che permettono loro di sostare sul tessuto arterioso danneggiato. Una volta ancorate, possono rilasciare farmaci quali paclitax ...

..::LIQUIDAREA::.. - liquidarea.com · Rank: 56,785 · 10 references

21 days ago by samspear

Why it’s Breakthrough: It’s a nanotechnology advance that potentially provides an alternative to drug-releasing stents in some patients with cardiovascular disease. The Story: The particles, dubbed “nanoburrs” because they are coated with tiny protein fragments that allow them to stick to target pro ...

Jump Into Tomorrow - jumpintotomorrow.com · 5 references

36 days ago by The Medical Quack

This is an interesting trial as it involved 4 competitors in the stent market. 20,000 individuals are slated to participate and Boston Scientific has signed on their first patient. The trials involve comparing the use of drugs after the placement of the stents and the use of aspirin to monitor which ...

The Medical Quack - ducknetweb.blogspot.com · Rank: 8,723 · 256 references

36 days ago by pharmafeed

Pfizer has dropped its Phase III trial evaluating figitumumab (CP-751,871) as an addition to paclitaxel and carboplatin therapy in patients with advanced nonadenocarcinoma non-small-cell lung cancer (NSCLC). The decision followed an analysis by the trial’s independent data safety monitoring committe ...

PharmaFeed - pharmafeed.com · Rank: 57,608 · 13 references

36 days ago by Marijke Durning, RN

A study looking at the effectiveness of the drug figitumumab in treating late-stage lung cancer has been stopped by the manufacturer, Pfizer Inc. Late-stage lung cancer is difficult to treat and researchers are continuously looking for different drug combinations that could help increase the surviva ...

Blisstree » Diseases & ... - blisstree.com · Rank: 69,471 · 622 references

57 days ago by Doctor Z

MayoClinic.org - Using Herceptin with chemotherapy, instead of after, clearly improves treatment of women with HER2+ breast cancer, and should be the new standard of care, says a Mayo Clinic researcher who led what is regarded to be a key clinical trial determining the best use of Herceptin. Patient ...

iHealthBulletin News - ihealthbulletin.com/blog · Rank: 27,595 · 57 references